Trademark: 97365235
Status Date
Wednesday, February 28, 2024
Filing Date
Friday, April 15, 2022
40 Manufacturing of pharmaceuticals, gene therapy products, and cell therapy products for others
5 Pharmaceutical preparations and therapeutic pharmaceuticals for the treatment of genetic diseases and disorders, genomic diseases and disorders, and cancer; gene therapy products, namely, genetically engineered DNA molecules and gene delivery pharmaceuticals for use in the treatment of genetic diseases and disorders, genomic diseases and disorders, and cancer; cell therapy products, namely, cells for medical and clinical use
42 Pharmaceutical research and development; research and development in the fields of gene therapy and cell therapy
Feb 28, 2024
Ex Parte Appeal-Instituted
Feb 28, 2024
Exparte Appeal Received At Ttab
Nov 27, 2023
Application Extension Granted/Receipt Provided
Nov 27, 2023
Application Extension To Response Period - Received
Aug 31, 2023
Notification Of Final Refusal Emailed
Aug 31, 2023
Final Refusal E-Mailed
Aug 31, 2023
Final Refusal Written
Aug 4, 2023
Teas/Email Correspondence Entered
Aug 3, 2023
Correspondence Received In Law Office
Aug 3, 2023
Teas Response To Office Action Received
May 2, 2023
Application Extension Granted/Receipt Provided
May 2, 2023
Application Extension To Response Period - Received
Feb 3, 2023
Notification Of Non-Final Action E-Mailed
Feb 3, 2023
Non-Final Action E-Mailed
Feb 3, 2023
Non-Final Action Written
Feb 2, 2023
Assigned To Examiner
Apr 20, 2022
New Application Office Supplied Data Entered
Apr 19, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24